drugset / Trial / NCT01556932

Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea

NCT01556932

RandomizedCrossoverDouble-blindSupportive care

Summary

This randomized clinical trial studies ABH (lorazepam, diphenhydramine hydrochloride, and haloperidol) gel in patients with nausea. ABH gel, when absorbed into the skin, may be an effective treatment for nausea and vomiting. The general purpose of this research study is to improve the treatment of nausea and vomiting.

Timeline

Start
2012-03
Primary completion
2013-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Diphenhydramine Unknown 25 mg Topical
Subject Haloperidol Other / unclassified 2 mg Topical
Subject Lorazepam Small molecule 2 mg Topical

Indications

No indication recorded.